Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended
Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 20,647,559	$ 11,278,493
General and administrative	1,846,276	1,269,044
Total operating expenses	22,493,835	12,547,537
Loss from operations	(22,493,835)	(12,547,537)
Other income (expense)
Interest expense	(1,400,712)	(1,242,012)
Interest income	2,282,092	1,851,132
Other income, net	881,380	609,120
Net loss before income taxes	(21,612,455)	(11,938,417)
Income tax benefits
Net loss	$ (21,612,455)	$ (11,938,417)
Net loss per share, basic	$ (0.64)	$ (0.55)
Net loss per share, diluted	$ (0.64)	$ (0.55)
Weighted average common shares outstanding, basic	33,612,054	21,680,877
Weighted average common shares outstanding, diluted	33,612,054	21,680,877

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.